Perimenopause typically starts in a woman’s mid-40s, with the estimated average onset around age 45 to 47 and a normal range from the early 40s to early 50s. The earliest signs (subtle cycle-length changes, sleep disruption, mood shifts) often appear years before periods become noticeably irregular, and missing them tends to mean treating each symptom as a separate problem instead of recognizing one underlying transition.
This guide covers the actual age range, the signs that show up earliest, what predicts an earlier start, and when to see a clinician. Most of what feels confusing about perimenopause is timing — the changes start before the cycle looks different, and the cycle looks different before classic symptoms like hot flashes show up.
What perimenopause actually is
Perimenopause is the transition into menopause — the years when ovarian function is gradually winding down, producing erratic hormone levels rather than a smooth decline. It begins with the first noticeable changes in cycle hormones or bleeding patterns and ends at menopause itself, defined as 12 consecutive months without a period. The transition typically lasts four to seven years across cohort studies, though individual variation is wide.
The clinical framework for staging perimenopause is the Stages of Reproductive Aging Workshop +10 (STRAW+10), which uses menstrual cycle bleeding patterns as the primary anchor, integrated with endocrine markers — follicle-stimulating hormone (FSH), anti-Müllerian hormone (AMH), and inhibin-B — and antral follicle count (Harlow SD et al., J Clin Endocrinol Metab 2012, PMID: 22344196; building on the original framework in Soules MR et al., J Womens Health Gend Based Med 2001, PMID: 11747678). Early perimenopause is defined by cycle-length variability of seven or more days. Late perimenopause is defined by 60 or more days of amenorrhea. The hormonal changes (rising FSH, falling AMH) happen alongside this, but the staging itself is anchored to what your cycles are actually doing.
The average starting age, and the actual range
Most women begin perimenopause in their mid-40s. The U.S. median age at the final menstrual period is 52.5 years (Gold EB et al., Am J Epidemiol 2013, PMID: 23788671), and perimenopause typically begins four to seven years earlier. That puts the estimated average onset around age 45 to 47, though the normal range stretches from the early 40s to the early 50s.
Some context on the range:
- Early 40s onset is common, not unusual. Some women begin perimenopause before age 40. About 1 percent meet diagnostic criteria for premature ovarian insufficiency (POI — ovarian decline before 40); a larger but unquantified group has early signs in their late 30s without meeting formal POI criteria.
- POI is the formal name for ovarian decline before 40. Premature ovarian insufficiency affects about 1 percent of women under 40 and around 0.1 percent under 30 (Webber L et al., ESHRE Guideline on POI, Hum Reprod 2016, PMID: 27008889). It requires clinical evaluation, not symptom-watching alone.
- Late starters exist too. Some women don’t enter perimenopause until their early 50s and reach menopause closer to age 55.
The wide range matters because “average” is a poor predictor for any individual. Cycle variability is genuinely irregular at both extremes of reproductive life (the foundational menstrual-diary work by Treloar AE et al., Int J Fertil 1967), which is part of why the late-30s and early-40s years are easy to misread. A few off cycles in this window can be early perimenopause, a stress response, or simply normal variation.
What predicts an earlier start
Several factors shift the timing forward, though none is determinative on its own. Smoking is the most consistently linked factor across cohort studies: women who smoke typically reach menopause about one to two years earlier than non-smokers. Lower body weight and certain autoimmune conditions are associated with earlier onset in some cohorts. Family history matters too — age at menopause is moderately heritable, so a mother’s or sister’s timing can be informative, though not deterministic. Bilateral oophorectomy causes immediate surgical menopause; chemotherapy and pelvic radiation often induce earlier ovarian failure. Race and ethnicity show differences in unadjusted comparisons, but these largely attenuate after controlling for sociodemographic, lifestyle, and health factors (Gold EB et al., Am J Epidemiol 2013, PMID: 23788671).
None of these factors changes what to do day-to-day. But if several apply, they shift the threshold for taking early symptoms seriously.
The earliest signs that often get missed
Hot flashes are the symptom most people associate with this transition, but they’re usually not the first thing to show up. The earliest signals tend to be quieter:
- Cycle-length variability. A few cycles drifting by three to five days isn’t unusual. Persistent variability of seven days or more is the STRAW+10 marker for early perimenopause.
- Sleep disruption, especially early-morning waking. Often described in clinical practice as the first noticed change, frequently misread as stress or aging.
- Mood shifts that track the luteal phase. New or worsening premenstrual symptoms. The hormonal turbulence in early perimenopause can amplify what was previously mild premenstrual sensitivity.
- Heart-rate variability (HRV) declines and cardiovascular reactivity changes. Resting heart rate trending up and HRV trending down across the luteal phase are commonly observed in wearable data, though formal clinical thresholds for perimenopause-related HRV changes have not been established.
- Breast tenderness. Often more intense or persistent than typical premenstrual tenderness (see Ultrahuman’s piece on why breasts may be sore or tender in perimenopause).
- Migraine pattern changes. New onset or shifts in timing relative to the cycle have been reported in clinical observation, though the menstrual-migraine literature specific to perimenopause is still developing.
- Hot flashes and night sweats. Common but usually later. Frequently appear in mid-to-late perimenopause, not at the very start.
One off cycle or one bad week of sleep isn’t perimenopause. Several of these showing up together, persisting over months, in your 40s, is what to pay attention to.
How to tell perimenopause apart from other things
A handful of conditions produce overlapping symptoms. A clinician will usually rule them out before settling on a perimenopause framing.
- Thyroid dysfunction. Hypothyroidism produces fatigue, weight changes, mood symptoms, and cycle changes. A thyroid-stimulating hormone (TSH) test is the standard first investigation.
- Stress and burnout. Cortisol disruption affects sleep, mood, and cycles. The pattern is usually tied to a life event rather than a slow build over years.
- Iron deficiency. Common in women with heavy periods. Produces fatigue and mood symptoms that mimic perimenopause.
- Premenstrual dysphoric disorder (PMDD). Severe luteal-phase mood symptoms can be PMDD rather than perimenopause, though the two can coexist and PMDD can intensify during the transition.
- Low progesterone patterns. Anovulatory cycles produce a separate symptom picture that overlaps with early perimenopause (covered in how low progesterone shows up in sleep, mood, and HRV).
There’s no single test that says “you are now in perimenopause.” Hormonal turbulence in this window makes single blood draws unreliable (see the full breakdown in can you test for perimenopause). What works better is consistent symptom and cycle tracking over several months, ideally before symptoms become severe.
What to track in the years before
If you’re in your late 30s or early 40s and want a baseline, four things give the most useful signal:
- Cycle length and bleeding patterns. Track every cycle. The seven-day variability threshold (per STRAW+10) needs several months of cycle data to assess reliably.
- Sleep quality and wake times. Persistent early-morning waking, even a few nights a month, can be informative. Track it alongside cycle phase.
- HRV and resting heart rate. Trends matter more than single readings. A gradual HRV decline alongside resting heart rate creep, both worse in the luteal phase, is a recognizable early pattern.
- Mood and energy patterns. Tied to cycle phase. Worsening luteal-phase symptoms over several cycles is meaningful.
Ultrahuman’s Cycle Aware Recovery view tracks resting heart rate, HRV, and skin temperature alongside cycle phase, which makes the gradual shifts easier to spot than they would be from memory alone. The point isn’t to diagnose perimenopause from wearable data. It’s to have a year or two of baseline to compare against when symptoms start to shift.
What Ring cycle data shows about when irregularity actually starts
The clinical marker for early perimenopause — cycle-length variability of seven or more days, persistent across cycles — is observable in Ring data. To see how often this actually happens in mid-life users, Ultrahuman analyzed cycle patterns from 6,296 women aged 40–55 who had at least three recorded cycles and at least two cycles longer than 35 days, a population-level proxy for the menstrual irregularity that marks the perimenopausal transition. That cohort produced 132,281 completed cycles, compared against a younger reference cohort of 186,230 women aged 20–39 (2,054,440 cycles).
Two patterns stand out:
- Long cycles become substantially more common. 24.0% of cycles in the 40–55 cohort ran longer than 35 days, versus 17.1% in the 20–39 reference — about a 7-percentage-point increase. The share of cycles longer than 60 days (the STRAW+10 late-perimenopause marker) was 8.0%, up from 5.1% in the younger reference.
- The variability widens, but the median cycle stays near-normal. Standard deviation across the 40–55 cohort was 24.2 days — about 18% wider than the 20–39 reference (20.5 days). The median cycle was still 28 days, near-normal. The shift isn’t that every cycle changes; it’s that the tail of unusually long ones grows.
Both patterns are visible at the population level by the early-to-mid 40s, often before women themselves register that their cycles have become noticeably less predictable. The practical implication for individual tracking: if you’re in your late 30s or 40s and your own long-cycle frequency is drifting up over six or twelve months, that’s the cycle-length irregularity STRAW+10 identifies as the early-perimenopause marker — and it’s measurable from Ring data alone.
Methodology note. Data above comes from anonymized records of Ring AIR users tracking cycles in the Ultrahuman app. The 40–55 cohort was defined by an analyst-applied filter, not by any prior perimenopause flag: women aged 40–55 whose Ring records contained at least 3 cycles AND at least 2 cycles longer than 35 days. Individual cycle lengths were bounded to the 5- to 365-day range to exclude data-quality outliers. The long-cycle pattern is a working proxy for the menstrual irregularity that marks perimenopause (recognized as the early marker in the STRAW+10 staging criteria), but it is not a clinical perimenopause diagnosis. So the figures show within-cohort prevalence under that filter, not population prevalence across all women aged 40–55. The 20–39 group is a younger reference, not an age-matched control. Observational wearable data, not a clinical study.
When to talk to a clinician
Most early perimenopause doesn’t need a workup. The cases that do:
- Under 40 with menopause-like symptoms. Needs evaluation for POI.
- Symptoms significantly affecting daily life. Severe sleep disruption, mood changes interfering with work, hot flashes affecting function.
- Heavy or irregular bleeding outside the typical perimenopause pattern. Rules out other gynecologic conditions before defaulting to a perimenopause explanation.
- You want to discuss hormone replacement therapy. Per current NAMS (North American Menopause Society) practice guidance, perimenopause testing isn’t typically required before HRT; a clinician can assess fit based on symptoms and clinical history. For the broader treatment landscape, see how to increase estrogen.
If a clinician orders hormone tests, ask what each test is meant to learn. That conversation usually clarifies whether the test is genuinely informative or routine.
This article is for informational purposes and is not medical advice. Perimenopause timing varies widely, and any persistent symptoms or significant cycle changes should be discussed with a clinician familiar with your individual history. Disclosure: Ultrahuman sells the Ring AIR and Ring PRO, which track cycle-related signals (skin temperature, HRV, resting heart rate) that some women use to monitor the changes associated with perimenopause.








